Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue

Details for Australian Patent Application No. 2008285473 (hide)

Owner Britannia Pharmaceuticals Limited

Inventors Lambert, Peter; Merkus, Franciscus W.H.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008285473

PCT Pub. Number WO2009/019463

Priority 0715285.3 06.08.07 GB

Filing date 4 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 31/375 (2006.01) - Ascorbic acid, i.e. vitamin C

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/019463 Priority application(s): WO2009/019463

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285476-Energy saving device

2008285467-Cooling apparatus and method